Therapixel

Private

NiceHealthcare & Life Scienceshttps://www.therapixel.com/

Last Round

Series B

May 12, 2022

Total Funding Raised

$23.1M

Company Overview

Therapixel is a healthtech company that provides AI-based medical imaging software to assist radiologists in breast cancer screening.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

medical imaging AIbreast cancer screeningsoftware as a medical deviceSaMDradiology AIdigital mammographydiagnostic decision supportPACS integrationRIS integrationclinical decision supportusage-based SaaSmedtechAI-powered diagnosticsdeep learning imagingradiology workflow

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Therapixel Comps

Public and private peers based on sector, stage, and business model.

Therapixel comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Therapixel Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	May 12, 2022
Series A	Mar 13, 2019
Grant	Jun 2, 2017
Seed	Nov 21, 2015

View all Funding Rounds

Key People

Founding team and executive leadership

Matthieu Leclerc-Chalvet

CEO

Executive Team

Therapixel Investors

Notable investors and investment history

Therapixel investors
Investor	Rounds
CapHorn Invest	Series B
Verve Ventures	Series B
Région Sud Investissement	Seed, Series A, Series B
Turenne Groupe	Seed
Arnold Ventures	Grant
M Capital	Series B, Series A
Crédit Mutuel Innovation	Series B

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Oct 1, 2025
Operating within CE mark and FDA regulated environment.
May 21, 2025
Partnered with RamSoft Inc. to integrate MammoScreen software.

View all signals

Therapixel Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Therapixel Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Therapixel's valuation, stock price, and market status.

Firmographic Details

HeadquartersNice

Employee Range61

Year Founded2013

Last FundingMay 12, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.